FeaturesSignalPricingFounders
Log inGet started free
RG

Redmile Group

Venture CapitalActive

Healthcare investment organization that does venture, growth and crossover investing across healthcare.

San Francisco, United StatesFounded 1996redmilegroup.com
95
Investments
54
Exits
$5.3B
AUM
56.8%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Redmile Group.

Get started free

Investment Thesis & Strategy

Redmile Group invests in various stages of healthcare companies, including venture, growth, and crossover rounds. They focus on healthcare investments across the sector.

Investment Activity

Deals per year over the last 4 years

3
2018
4
2019
2
2020
3
2021

Portfolio Companies

Selected investments from their portfolio of 95 companies

C
Carmot Therapeutics
Biotech · Series B, 2021
Active
K
Kyverna Therapeutics
Biotech · Series B, 2021
Active
V
Ventyx Biosciences
Biotech · Series B, 2021
Active
C
Cerevel Therapeutics
Biotech · Growth, 2020
Active
A
Acumen Pharmaceuticals
Biotech · Series A, 2020
Active
S
Sana Biotechnology
Biotech · Growth, 2019
Active
L
Lyell Immunopharma
Biotech · Series B, 2019
Active
V
Verve Therapeutics
Biotech · Series B, 2019
Active
O
Obsidian Therapeutics
Biotech · Series B, 2019
Active
V
Vaxcyte
Biotech · Series B, 2018
Active
T
Turning Point Therapeutics
Biotech · Growth, 2018
Active
G
Gossamer Bio
Biotech · Series B, 2018
Active

Frequently Asked Questions

Redmile Group focuses on Series A, Series B, Series C+ stage investments.

Related Investors

Index Ventures

San Francisco, United States · 827 deals

First Round Capital

San Francisco, United States · 742 deals

Benchmark

San Francisco, United States · 600 deals

Founders Fund

San Francisco, United States · 564 deals

Matrix Partners

San Francisco, United States · 549 deals

Bain Capital Ventures

San Francisco, United States · 438 deals